Inicio › Cáncer de vejiga › Illinois
Ensayos clínicos de Cáncer de vejiga en Illinois
30 estudios sobre Cáncer de vejiga buscan participantes en Illinois.
Ciudades en Illinois
- Chicago21 estudios
- Cicero7 estudios
- Evanston7 estudios
- Joliet6 estudios
- Springfield6 estudios
- Decatur6 estudios
- Danville4 estudios
- Champaign4 estudios
- Charleston4 estudios
- Naperville4 estudios
- Bloomington4 estudios
- Peoria4 estudios
- Aurora3 estudios
- Arlington Heights3 estudios
- Galesburg3 estudios
- Waukegan3 estudios
- North Peoria3 estudios
Texto oficial del estudio (inglés)
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Rush MD Anderson Cancer Center, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Carle at The Riverfront, Danville
- y 12 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT03866382Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Rush-Copley Medical Center, Aurora
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- y 38 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07061964A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
- Associated Urological Specialists - Chicago Ridge ( Site 0139), Chicago Ridge
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06833073Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
- Memorial Hospital, Shiloh
- Siteman Cancer Center - Shiloh, Shiloh
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07421700A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
- Northwestern Memorial Hospital, Chicago
- Northwestern University - Feinberg School of Medicine, Chicago
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07206225A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- City of Hope Cancer Center-Chicago, Zion
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07277413Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Rush MD Anderson Cancer Center, Chicago
- Carle at The Riverfront, Danville
- Cancer Care Specialists of Illinois - Decatur, Decatur
- y 11 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06770582A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- University of Illinois Cancer Center, Chicago
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06172478DESTINY-PANTUMOUR04
- Research Site, Decatur
ReclutandoEstudio observacional
Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- University of Illinois at Chicago, Chicago
- University of Chicago Medical Center, Chicago
- Endeavor Health, Evanston
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07218380Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Illinois Cancer Specialists, Niles
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07566156A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Chicago Hospital, Chicago
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06465069Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
- Associated Urological Specialists, Chicago Ridge
- Uropartners, Glenview
- Accellacare, Lisle
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06567743Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- y 54 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05334069KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- University of Chicago Medical Center ( Site 5037), Chicago
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07232602Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
- Comprehensive Urologic Care, Lake Barrington
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT05951179Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
- Research Site, Niles
- Research Site, Peoria
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT07129993FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- The University of Chicago Medical Center (UCMC), Chicago
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT05614739Measuring Surgical Recovery After Radical Cystectomy
- University of Chicago, Chicago
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT03193970Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- OSF Saint Anthony's Health Center, Alton
- OSF Saint Joseph Medical Center, Bloomington
- Illinois CancerCare-Bloomington, Bloomington
- y 32 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07097142Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
- Northwestern University, Chicago
- University of Illinois, Chicago
- Loyola University Medical Center, Maywood
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07000084A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- UChicago Medicine - River East, Chicago
- University of Chicago Medical Center, Chicago
- Accellacare - Deerfield, Deerfield
- y 5 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT04879329A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Ingalls Family Care Center, Calumet City
- UChicago Medicine - River East, Chicago
- The University Of Chicago, Chicago
- y 13 más
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 jul 2026 · NCT04389632Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
- Northwestern University, Chicago
- Northwestern Medicine Orland Park, Orland Park
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06630416A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- The University of Chicago Comprehensive Cancer Center, Chicago
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 feb 2026 · NCT06778863Blue Light Cystoscopy With Cysview® Registry
- Northwestern University, Chicago
- Northshore University Health System, Evanston
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 dic 2025 · NCT02660645SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774Prospective Validation Study of High Volume Urine DNA Testing in Individuals With Suspicion of Urothelial Cancer
- Jesse Brown Department Of Veterans Affairs Medical Center, Chicago
ReclutandoEstudio observacional
Edades de 18 a 100 · Todos los sexos · Actualizado el 10 oct 2025 · NCT06310759Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Reclutando
Edades de 65 en adelante · Todos los sexos · Actualizado el 3 oct 2025 · NCT06427824De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.